ArticleRegenerative biomaterials2026
The Sr-HA-loaded PLGA cage structure combines cells to construct a bone tissue repair unit.
Article in Regenerative biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoporosis arises from an imbalance where bone resorption outpaces formation, reducing bone mass and mineral density while elevating fracture risk. Subsequent surgical repair of these fractures in compromised bone is prone to cause secondary injury, further increasing the challenges of recovery. In this study, we developed an injectable bone repair unit based on multicellular delivery microspheres, designed to promote the repair of osteoporotic bone defects through the synergistic effect of cells and metal ions. First, cage-structured PLGA microspheres (PLGA-CAS) were fabricated via the double-emulsion technique. Subsequently, the surfaces of the PLGA-CAS were uniformly coated with needle-like strontium-doped hydroxyapatite (Sr-HA) particles synthesized by wet-chemical precipitation to form Sr-HA-coated PLGA-CAS (SrHP). Finally, mouse pre-osteoblasts (MC3T3-E1) and human umbilical vein endothelial cells (HUVECs) were separately cultured on the SrHP microspheres, which together constituted the final bone repair unit. Structural and compositional analyses revealed that the PLGA-CAS scaffold possessed an interconnected porous structure with successfully anchored Sr-HA particles. Both SrHP loaded with MC3T3-E1 (M-SrHP) and with HUVECs (H-SrHP) exhibited high cell viability and injectability. Notably, the blended microsphere system incorporating both M-SrHP and H-SrHP (MH-SrHP) simultaneously facilitated osteogenic differentiation, promoted angiogenesis and inhibited osteoclast differentiation
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.